P426 Supra-therapeutic infliximab levels are not associated with a higher risk of infection in IBD patients

Autor:	B. Kabakchiev, Tomer Greener, Mark S. Silverberg
Rok vydání:	2017
Předmět:	medicine.medical_specialty business.industry Internal medicine Risk of infection Gastroenterology medicine General Medicine business Infliximab medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 11:S293-S294
ISSN:	1876-4479 1873-9946
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::89e14d1c29709e018a6b950bfd16c15a https://doi.org/10.1093/ecco-jcc/jjx002.551 Zobrazit plný text záznamu